Correlation Between Kane Biotech and Roivant Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kane Biotech and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kane Biotech and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kane Biotech and Roivant Sciences, you can compare the effects of market volatilities on Kane Biotech and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kane Biotech with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kane Biotech and Roivant Sciences.

Diversification Opportunities for Kane Biotech and Roivant Sciences

KaneRoivantDiversified AwayKaneRoivantDiversified Away100%
-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kane and Roivant is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Kane Biotech and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Kane Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kane Biotech are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Kane Biotech i.e., Kane Biotech and Roivant Sciences go up and down completely randomly.

Pair Corralation between Kane Biotech and Roivant Sciences

If you would invest  268.00  in Roivant Sciences on October 15, 2024 and sell it today you would earn a total of  0.00  from holding Roivant Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.59%
ValuesDaily Returns

Kane Biotech  vs.  Roivant Sciences

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -40-200204060
JavaScript chart by amCharts 3.21.15KNBIF ROIVW
       Timeline  
Kane Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kane Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
JavaScript chart by amCharts 3.21.15NovDecJanDecJan0.0650.070.0750.080.0850.090.095
Roivant Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roivant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Roivant Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Kane Biotech and Roivant Sciences Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-7.16-5.36-3.56-1.770.01.643.345.046.738.43 0.0150.0160.0170.0180.0190.020
JavaScript chart by amCharts 3.21.15KNBIF ROIVW
       Returns  

Pair Trading with Kane Biotech and Roivant Sciences

The main advantage of trading using opposite Kane Biotech and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kane Biotech position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.
The idea behind Kane Biotech and Roivant Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance